Vimarsana
Biggest News Aggregation in the World

Page 9 - Pharma Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Corp Today - Breaking & Trending Today

These Are The Top 10 Holdings Of David Kim - Vimarsana News

These Are The Top 10 Holdings Of David Kim

We have used the latest available 13F filing (as of Dec. 31, 2023) of Ghost Tree Capital to come up with the top 10 holdings of David Kim.

Polycystic Kidney Disease Drugs Market Expand CAGR of ~7%, Driving Factors, Size, Revenue & Opportunities 2023-2033 - Vimarsana News

Polycystic Kidney Disease Drugs Market Expand CAGR of ~7%, Driving Factors, Size, Revenue & Opportunities 2023-2033

The global polycystic kidney disease drugs market is expected to reach an estimated value of ~USD 732 Million by 2033, by expanding at a CAGR of ~7%.

CTI BioPharma Corp. (NASDAQ:CTIC) CEO Adam R. Craig Sells 84,683 Shares - Vimarsana News

CTI BioPharma Corp. (NASDAQ:CTIC) CEO Adam R. Craig Sells 84,683 Shares

CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) CEO Adam R. Craig sold 84,683 shares of CTI BioPharma stock in a transaction dated Tuesday, January 3rd. The stock was sold at an average price of $6.01, for a total value of $508,944.83. Following the completion of the sale, the chief executive officer now directly owns 29,440 […]

Acute Myeloid Leukemia Therapeutics Market Research Report - Vimarsana News

Acute Myeloid Leukemia Therapeutics Market Research Report

The Global Acute Myeloid Leukemia Therapeutics Market size was estimated at USD 671. 34 million in 2021 and expected to reach USD 757. ...

RAMM Pharma Corp. Announces Appointment of new Interim-Chief Financial Officer - Vimarsana News

RAMM Pharma Corp. Announces Appointment of new Interim-Chief Financial Officer

TORONTO, Dec. 09, 2022 (GLOBE NEWSWIRE) — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “